Cargando…

Dihydropyridine Calcium Channel Blockers and the Risk of Severe COVID-19

Detalles Bibliográficos
Autores principales:	Mendez, Sean R., Frank, Rachel C., Stevenson, Elizabeth K., Chung, Mabel, Silverman, Michael G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians. Published by Elsevier Inc. 2021
Materias:	Chest Infections: Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857077/ https://www.ncbi.nlm.nih.gov/pubmed/33548220 http://dx.doi.org/10.1016/j.chest.2021.01.073

Ejemplares similares

THE MULBSTA SCORE: PREDICTING RISK OF MORTALITY AND DISEASE SEVERITY IN PATIENTS WITH COVID-19 PNEUMONIA
por: Tusha, Jurgena, et al.
Publicado: (2020)

UNEXPECTED OPPORTUNISTIC INFECTION IN PATIENT WITH SEVERE COVID-19 PNEUMONIA
por: NIEVES, HÉCTOR, et al.
Publicado: (2021)

ATYPICAL PAROTITIS AS A RESULT OF SEVERE COVID-19 INFECTION
por: MARCANO, ANDREW, et al.
Publicado: (2021)

SEVERE/REFRACTORY IMMUNE THROMBOCYTOPENIA IN MILD COVID-19 DISEASE
por: MENON, TRISHALA, et al.
Publicado: (2021)

SPECTRUM OF COVID-19 SEVERITY IN YOUNG ADULTS: A CASE SERIES
por: Riera, Maria Bernal, et al.
Publicado: (2020)

GIRAFFE IN THE COVID-19 LUNG: PULMONARY FIBROSIS LIMITING SEVERITY OF THE PNEUMOTHORAX
por: ALLEN CHAN, MARVYN, et al.
Publicado: (2021)

SEVERE COVID-19 PNEUMONIA IN A FULLY VACCINATED IMMUNOCOMPROMISED PATIENT
por: SUBRAMANIAN, LAKSHMI, et al.
Publicado: (2021)

CASE REPORT OF SEVERE PULMONARY FIBROSIS AS A SEQUELAE OF COVID-19 INFECTION
por: Arjun, Shiva, et al.
Publicado: (2020)

CATASTROPHIC STROKE DESPITE ASPIRIN AND THERAPEUTIC ENOXAPARIN IN PATIENT WITH SEVERE COVID-19
por: Condit, Daniel, et al.
Publicado: (2020)

SEVERE ALLERGIC ERYTHEMATOUS REACTION POSTMESSENGER RNA-BASED COVID-19 VACCINE
por: ALI, RUHMA, et al.
Publicado: (2022)

Dihydropyridine Calcium Channel Blockers and Risk of Pancreatic Cancer: A Population‐Based Cohort Study
por: Rouette, Julie, et al.
Publicado: (2022)

BLOOD TYPE AND MALE SEX AS POTENTIAL PREDICTORS OF SUSCEPTIBILITY, SEVERITY, AND OUTCOMES IN COVID-19
por: MA, EVA, et al.
Publicado: (2021)

POST-COVID-19 SYNDROME: CHARACTERIZATION OF A COHORT AND ASSOCIATION WITH ACUTE DISEASE SEVERITY
por: OLIVEIRA BAPTISTA DA SILVA, FERNANDA, et al.
Publicado: (2021)

PREVOTELLA BIVIA BACTEREMIA POST TOCILIZUMAB IN A PATIENT WITH SEVERE COVID-19 PNEUMONIA
por: AIYANYOR, ALFRED, et al.
Publicado: (2021)

SINUS BRADYCARDIA AS A PREDICTOR OF SEVERITY OF COVID-19 INFECTION: TRANQUILITY BEFORE CHAOS
por: ARSALAN ZAIDI, SYED, et al.
Publicado: (2021)

PREDICTING COVID-19 SEVERITY USING A SIMPLE PARAMETERS IN RESOURCE-LIMITED SETTINGS
por: NIMITVILAI, S., et al.
Publicado: (2022)

FACTORS AFFECTING OUTCOMES IN PATIENTS WITH SEVERE COVID-19 WHO RECEIVED CONVALESCENT PLASMA THERAPY
por: SRIDEVI, T., et al.
Publicado: (2022)

SEVERE ADENOVIRUS PNEUMONIA IN RITUXIMAB INFUSIONS
por: BJORK, SARAH, et al.
Publicado: (2021)

E. COLI PNEUMONIA WITH PNEUMATOCELE, EMPYEMA NECESSITANS, AND BRONCHOPLEURAL FISTULA IN A PATIENT WITH SEVERE COVID-19
por: Kahn, Michael, et al.
Publicado: (2020)

THE IMPACT OF COVID-19 VACCINATION ON DISEASE SEVERITY AND OUTCOMES IN HOSPITALIZED PATIENTS: A REAL-WORLD EXPERIENCE
por: SATISH, V., et al.
Publicado: (2022)

COMPARISON OF SEVERITY AND CLINICAL OUTCOMES OF PATIENTS WITH COVID-19 FROM MULTIETHNIC BACKGROUNDS IN A TERTIARY CARE CENTER
por: SELVARAJ, J., et al.
Publicado: (2022)

TNF/IFN-GAMMA AXIS FAVORS SENESCENCE AND SEVERE INFLAMMATION ASSOCIATED WITH CELL DEATH IN PATIENTS WITH COVID-19
por: PALACIOS, Y., et al.
Publicado: (2022)

SEVERE PULMONARY BLASTOMYCOSIS IN A PATIENT WITH A COVID-19-POSITIVE TEST: A DANGEROUS ANCHORING BIAS
por: DURDEVIC, MOMCILO, et al.
Publicado: (2022)

COVID-19: ESSENTIAL WORKERS AND THE RISKS WE FACE
por: MAHMOOD, SYED, et al.
Publicado: (2021)

SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 ISOLATION FROM PLEURAL FLUID WITH COVID-19 PNEUMONIA AND SUPERIMPOSED EMPYEMA
por: Leys, Lorenzo, et al.
Publicado: (2020)

THE ROLE OF ASCORBIC ACID IN REDUCING MORTALITY IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: KHOKHER, WALEED, et al.
Publicado: (2021)

TIME TO EXPAND THE USE OF CASIRIVIMAB/IMDEVIMAB MONOCLONAL ANTIBODY THERAPY? A CASE OF COMPASSIONATE USE IN SEVERE COVID-19 PNEUMONIA
por: AHMED, MUBASHIR AYAZ, et al.
Publicado: (2022)

PROLONGED COVID-19 IN PATIENTS TREATED WITH RITUXIMAB
por: WEBER, ANDREW, et al.
Publicado: (2021)

PNEUMOTHORAX IN SEVERE ILL PATIENTS ADMITTED DUE TO SARS-COV-2
por: Uribe, Juan Pablo, et al.
Publicado: (2020)

FERRITIN-GUIDED THERAPEUTIC PLASMA EXCHANGE (TPE) ADMINISTRATION IN COVID-19-INDUCED CYTOKINE STORM SYNDROME: A CASE SERIES
por: MASI, SEAN M, et al.
Publicado: (2022)

D-DIMER AS A SURROGATE MARKER OF DISEASE SEVERITY IN AFRICAN AMERICAN POPULATION WITH COVID-19 PNEUMONIA: A COMMUNITY HOSPITAL RETROSPECTIVE STUDY
por: OMORE, IBRAHIM, et al.
Publicado: (2021)

ELDERLY PERSON WITH COVID-19 AND SEVERE ARDS WITH PROLONGED ACTIVE VIRAL REPLICATION AND DOUBLE RESURGENCE OF CYTOKINE STORM TREATED WITH SOTROVIMAB AND CASIRIVIMAB/IMDEVIMAB
por: SIRITHANAKUL, KASEM
Publicado: (2022)

DOES COVID-19 INCREASE YOUR RISK OF DEVELOPING HAIRY CELL LEUKEMIA?
por: MANDAL, SHOBHA, et al.
Publicado: (2022)

FULMINANT MYOCARDITIS IN A PATIENT WITH SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2
por: Tavares, Matthew, et al.
Publicado: (2020)

CT CHEST FINDINGS IN SEVERE MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS INFECTION
por: ALKINDI, F., et al.
Publicado: (2022)

SPIROMETRY IN COVID-19 PNEUMONIA PATIENTS ON CONTINUOUS REMOTE PATIENT MONITORING
por: LOUDERMILK, KEVIN, et al.
Publicado: (2021)

Dihydropyridine-derived calcium channel blocker as a promising anti-hantavirus entry inhibitor
por: Wang, Bin, et al.
Publicado: (2022)

INCREASED RISK OF MECHANICAL VENTILATION AND DEATH IN PATIENTS WITH COVID-19 RECENTLY TREATED WITH RITUXIMAB
por: MILES, B., et al.
Publicado: (2022)

RISK FACTORS FOR COVID-19 CRITICAL ILLNESS AMONG TWO URBAN PUBLIC HOSPITALS
por: GRAZIANI, CASEY, et al.
Publicado: (2022)

IMPACT OF DEMENTIA AS AN EARLY MORTALITY RISK FACTOR AMONG DECEASED PATIENTS WITH COVID-19
por: RUIZ, CARLOS A PEREZ, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3t7i7f5sb3jdcneed6k7c6laok